Retinoic acid metabolism

Journal of the American Academy of Dermatology

Volumn 45, Issue 5, 2001, Pages

  Petkovich, P Martin ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; RETINOIC ACID;

CELL PROTECTION; CONFERENCE PAPER; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034764211     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.113715     Document Type: Conference Paper

References (55)

1. Cellular biology and biochemistry of the retinoids
2. Retinoids in cancer chemoprevention
3. Squamous differentiation and retinoids
4. Embryonic development and pattern formation
5. Treatment of severe psoriasis with systemic drugs
6. Molecular mechanisms of retinoid actions in skin
7. The use of isotretinoin in disorders of keratinization
8. Retinoids and human cancer
9. A decade of molecular biology of retinoic acid receptors
10. Retinoic acid receptors and cellular binding proteins: Complex interplay in retinoid signalling
11. Retinoic acid synthesis from beta-carotene in vivo
12. Biosynthesis and metabolism of retinoic acid: Roles of CRBP and CRABP in retinoic acid: Roles of CRBP and CRABP in retinoic acid homeostasis
13. Retinoic acid biosynthesis and metabolism
14. Enzymes and binding proteins affecting retinoic acid concentrations
15. Retinoids and the alcohol dehydrogenase gene family
16. Retinoic acid synthesizing enzymes in the embryonic and adult vertebrate
17. Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development
18. Bioactivities of N-(4-hydroxyphenyl) retinimide and retinoyl B-glucuronide
19. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo
20. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats
21. Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid
22. Inhibition of retinoic acid metabolism by imidazole antimycotics in F9 embryonal carcinoma cells
23. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells
24. Human skin levels of retinoic acid and cytochrome p-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro
25. Isolation and identification of 4-hydroxy- and 4-oxoretinoic acid: In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver
26. Retinoid-dependent induction of the in vivo and in vitro metabolism of retinoic acid in tissues of the vitamin A-deficient hamster
27. Identification of the retinoic acid-inducible all trans retinoic acid 4-hydroxylase
28. Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos
29. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family
30. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha
31. Regionalized metabolic activity establishes boundaries of retinoic acid signaling
32. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450
33. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7
34. A molecular basis for retinoic acid-induced axial truncation
35. Identification and spatial distribution of retinoids in the developing chick limb bud
36. Developmental analysis of the retinoic acid-inducible RAR-2 promoter in transgenic animals
37. Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis
38. Dorsal and ventral retinal territories defined by retinoic acid synthesis, break-down and nuclear receptor expression
39. Retinoic acid: Biochemistry, toxicology, pharmacology, and therapeutic use
40. Retinoids and cancer in experimental animals
41. Retinoids and chemoprevention: Clinical and basic studies
42. Clinical pharmacology of all-trans retinoic acid
43. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia
44. Retinoid differentiation therapy in promyelocytic leukemia
45. Applications for retinoids in cancer therapy
46. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience
47. Modulation of all-trans retinoic acid pharmacokinetics in acute promyelocytic leukemia by prolonged interferon therapy
48. Liarozole-A novel treatment approach for advanced prostate cancer. Results of a large randomized trial versus cyproterone acetate
49. Early clinical experience with Liarozole (Liazal [TM]) in patients with progressive prostate cancer
50. Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid
51. Retinoic acid receptors regulate expression of RA 4-hydroxylase that specifically inactivates all-trans RA in human keratinocyte HaCaT cells
52. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vitro
53. Effects of systematic treatment with liarozole on cutaneous inflammation, epidermal proliferation and differentiation in the extensive plaque psoriasis
54. The effects of liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin